Skip to main content
Journal of Virology logoLink to Journal of Virology
. 1968 Jan;2(1):7–14. doi: 10.1128/jvi.2.1.7-14.1968

Characterization of the Tumorlike (T) Antigen Induced by Type 12 Adenovirus 1

I. Purification of the Antigen from Infected KB Cells and a Hamster Tumor Cell Line

Z Gilead 1,2, H S Ginsberg 1
PMCID: PMC375571  PMID: 5742029

Abstract

The T antigen induced by type 12 adenovirus was purified from KB cells infected in the presence of 10−6m 5-fluoro-2-deoxyuridine to inhibit synthesis of viral capsid antigens. The antigen was purified approximately 200-fold, and the purified product contained only negligible amounts of host-cell contaminants, as judged by the residual radioactivity from 14C-labeled uninfected cells which had been added to infected cells at the initiation of the purification. Immunoelectrophoresis indicated that the purified T-antigen preparation contained a single antigenic species. The T antigen from a hamster cell line (HT-1) derived from a type 12 adenovirus-induced tumor was purified by the same procedure. The T antigens from the two different sources were shown to be immunologically similar by use of a rabbit antiserum prepared against the purified T antigen from infected KB cells and sera from hamsters bearing tumors induced by type 12 adenovirus.

Full text

PDF
7

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. EAGLE H. Amino acid metabolism in mammalian cell cultures. Science. 1959 Aug 21;130(3373):432–437. doi: 10.1126/science.130.3373.432. [DOI] [PubMed] [Google Scholar]
  2. EAGLE H. Propagation in a fluid medium of a human epidermoid carcinoma, strain KB. Proc Soc Exp Biol Med. 1955 Jul;89(3):362–364. doi: 10.3181/00379727-89-21811. [DOI] [PubMed] [Google Scholar]
  3. EDDY B. E., GRUBBS G. E., YOUNG R. D. TUMOR IMMUNITY IN HAMSTERS INFECTED WITH ADENOVIRUS TYPE 12 OR SIMIAN VIRUS 40. Proc Soc Exp Biol Med. 1964 Nov;117:575–579. doi: 10.3181/00379727-117-29642. [DOI] [PubMed] [Google Scholar]
  4. FLANAGAN J. F., GINSBERG H. S. Synthesis of virus-specific polymers in adenovirus-infected cells; effect of 5-fluorodeoxyuridine. J Exp Med. 1962 Aug 1;116:141–157. doi: 10.1084/jem.116.2.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Feldman L. A., Rapp F. Inhibition of adenovirus replication by 1-beta-D-arabinofuranosylcytosine. Proc Soc Exp Biol Med. 1966 May;122(1):243–247. [PubMed] [Google Scholar]
  6. GESSLER A. E., BENDER C. E., PARKINSON M. C. A new and rapid method for isolating viruses by selective fluorocarbon deproteinization. Trans N Y Acad Sci. 1956 Jun;18(8):701–703. doi: 10.1111/j.2164-0947.1956.tb00497.x. [DOI] [PubMed] [Google Scholar]
  7. GINSBERG H. S., BADGER G. F., DINGLE J. H., JORDAN W. S., Jr, KATZ S. Etiologic relationship of the RI-67 agent to acute respiratory disease (ARD). J Clin Invest. 1955 Jun;34(6):820–831. doi: 10.1172/JCI103137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. GRUNBAUM B. W., DONG L. Immunoelectrophoresis with cellulose acetate. Nature. 1962 Apr 14;194:185–186. doi: 10.1038/194185a0. [DOI] [PubMed] [Google Scholar]
  9. Gilead Z., Ginsberg H. S. Characterization of a Tumorlike Antigen in Type 12 and Type 18 Adenovirus-Infected Cells. J Bacteriol. 1965 Jul;90(1):120–125. doi: 10.1128/jb.90.1.120-125.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gilead Z., Ginsberg H. S. Comparison of the rates of ultraviolet inactivation of the capacity of type 12 adenovirus to infect cells and to induce T antigen formation. J Bacteriol. 1966 Dec;92(6):1853–1854. doi: 10.1128/jb.92.6.1853-1854.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. HOGGAN M. D., ROWE W. P., BLACK P. H., HUEBNER R. J. PRODUCTION OF "TUMOR-SPECIFIC" ANTIGENS BY ONCOGENIC VIRUSES DURING ACUTE CYTOLYTIC INFECTIONS. Proc Natl Acad Sci U S A. 1965 Jan;53:12–19. doi: 10.1073/pnas.53.1.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. HUEBNER R. J., ROWE W. P., TURNER H. C., LANE W. T. SPECIFIC ADENOVIRUS COMPLEMENT-FIXING ANTIGENS IN VIRUS-FREE HAMSTER AND RAT TUMORS. Proc Natl Acad Sci U S A. 1963 Aug;50:379–389. doi: 10.1073/pnas.50.2.379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hollinshead A. C., Huebner R. J. Adenovirus 12 virion-free "T" antigen from infected cells inhibited with cytosine arabinoside. Nature. 1966 Jun 25;210(5043):1381–1383. doi: 10.1038/2101381b0. [DOI] [PubMed] [Google Scholar]
  14. KITAMURA I., VAN HOOSIER G., Jr, SAMPER L., TAYLOR G., TRENTIN J. J. CHARACTERISTICS OF HUMAN ADENOVIRUS TYPE 12 INDUCED HAMSTER TUMOR CELLS IN TISSUE CULTURE. Proc Soc Exp Biol Med. 1964 Jul;116:563–568. doi: 10.3181/00379727-116-29307. [DOI] [PubMed] [Google Scholar]
  15. KOHN J. A micro-electrophoretic method. Nature. 1958 Mar 22;181(4612):839–840. doi: 10.1038/181839a0. [DOI] [PubMed] [Google Scholar]
  16. Kalnins V. I., Stich H. F., Yohn D. S. Electron microscopic localization of virus-associated antigens in human amnion cells (AV-3) infected with human adenovirus, type 12. Virology. 1966 Apr;28(4):751–754. doi: 10.1016/0042-6822(66)90259-5. [DOI] [PubMed] [Google Scholar]
  17. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  18. Lawrence W. C., Ginsberg H. S. Intracellular uncoating of type 5 adenovirus deoxyribonucleic acid. J Virol. 1967 Oct;1(5):851–867. doi: 10.1128/jvi.1.5.851-867.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Levinthal J. D., Ahmad-Zadeh C., Van Hoosier G., Jr, Trentin J. J. Immunofluorescence of human adenovirus type 12 in various cell types. Proc Soc Exp Biol Med. 1966 Feb;121(2):405–414. doi: 10.3181/00379727-121-30791. [DOI] [PubMed] [Google Scholar]
  20. POPE J. H., ROWE W. P. IMMUNOFLUORESCENT STUDIES OF ADENOVIRUS 12 TUMORS AND OF CELLS TRANSFORMED OR INFECTED BY ADENOVIRUSES. J Exp Med. 1964 Oct 1;120:577–588. doi: 10.1084/jem.120.4.577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Riggs J. L., Takemori N., Lennette E. H. Detection of adenovirus type 12 neoantigen (s) in a continuous human amnion cell line (FL) by immunofluorescence. Proc Soc Exp Biol Med. 1965 Dec;120(3):832–837. doi: 10.3181/00379727-120-30668. [DOI] [PubMed] [Google Scholar]
  22. Rouse H. C., Strohl W. A., Schlesinger R. W. Properties of cells derived from adenovirus-induced hamster tumors by long-term in vitro cultivation. I. Clonal stability of three biological characteristics. Virology. 1966 Apr;28(4):633–644. doi: 10.1016/0042-6822(66)90248-0. [DOI] [PubMed] [Google Scholar]
  23. Rowe W. P., Baum S. G., Pugh E., Hoggan M. D. Studies of adenovirus SV40 hybrid viruses. I. Assay system and further evidence for hybridization. J Exp Med. 1965 Nov 1;122(5):943–954. doi: 10.1084/jem.122.5.943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. SEVER J. L. Application of a microtechnique to viral serological investigations. J Immunol. 1962 Mar;88:320–329. [PubMed] [Google Scholar]
  25. Sjögren H. O., Minowada J., Ankerst J. Specific transplantation antigens of mouse sarcomas induced by adenovirus type 12. J Exp Med. 1967 Apr 1;125(4):689–701. doi: 10.1084/jem.125.4.689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Trentin J. J., Bryan E. Virus-induced transplantation immunity to human adenovirus type 12 tumors of the hamster and mouse. Proc Soc Exp Biol Med. 1966 Apr;121(4):1216–1219. doi: 10.3181/00379727-121-31009. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES